Concepedia

Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer

Isamu Okamoto, Akinobu Hamada, Yusuke Matsunaga, Ji-ichiro Sasaki, Shinji Fujii, Hideshi Uramoto, Haruhiko Yamagata, Ichiro Mori, Hiroto Kishi, Hiroshi Semba,

Cancer Chemotherapy and Pharmacology · 2005 · 30 citations · 14 references

DOI

Concepts

References

14

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture

Mary J. Kuffel, Joel M. Reid, Matthew M. Ames · Cancer Chemotherapy and Pharmacology · 1992 · 115 citations

, , +15

A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II‐DNA Complex

Mitsuharu Hanada, Satoko Mizuno, Akihisa Fukushima et al. · Japanese Journal of Cancer Research · 1998 · 107 citations · Full text

, , +16

Cytotoxicity of Amrubicin, a Novel 9‐Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells

Takashi Yamaoka, Mituharu Hanada, Shinji Ichii et al. · Japanese Journal of Cancer Research · 1998 · 100 citations · Full text

, , +11

Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites.

Robert F. Ozols, James K. V. Willson, Martin D. Weltz et al. · PubMed · 1980 · 88 citations

, , +14